Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma Patients
Clinical trial NCT05611463 · UNKNOWN
Trial details
- NCT number
- NCT05611463
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-02
- Primary completion
- 2022-12-02
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.